2017•University of Bridgeport ScholarWorks (University of Bridgeport)Requires access
Hemolytic disease of the new born - Erythroblastosis Fetalis
Suman Lata Khatri
Open publisher page 0 citations
Abstract
The study aims at knowing what is Erythroblastosis Fetalis, how it is caused and what are different methods of treatments. During exposure to Rh+ blood cells, Rh-ve mother becomes sensitized and there will be synthesis of anti-Rh antibody in her body. These antibodies cross the placenta and there will be destruction of red blood cells of Rh+ baby. The child will be anemic and there will be development of Jaundice. There will be elevated bilirubin levels. On the infant’s tissue, elevated bilirubin level can be fixed(Dawson & Milne, 1967).